FDA Determines Regulatory Review Period for Monostrut Cardiac Valve Prosthesis Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for the MonostrutTM Cardiac Valve Prosthesis, a medical device, in order to extend the patent that covers it, as required by law.